Skip to main content

Table 2 PEG-J replacement procedures: “pull” and “push” methods comparison

From: PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study

 

“pull” n=41

“push” n=79

Clinical characteristicsb

Mean

range

SD

Mean

range

SD

 Age (years)

72.6

63-84

± 7.0

73,2

63-84

± 6.6

 Disease duration (years)

19.8

15-35

± 5.7

18.6

12-35

± 5.7

 Follow-up duration (months)

77.4

3-119

± 4.4

64.9

15-119

± 3.4

 MDS-UPDRS pt. III score

28.0

4-54

± 2.3

34.4

10-66

± 1.4

 mH&Y stage

2.9

2.5-4

± 0.6

3.0

2.5-4

± 0.5

 PEG-J duration (months)

7.7

0-27

± 5.9

5.7

0-27

± 4.9

Reason for replacementc

n

%

 

n

%

 

 Scheduled replacements

12

29.3

 

36

45.6

 

 Stoma complicationsa

6

14.6

 

9

11.4

 

 Unexpected replacements

29

70.7

 

43

54.4

 

 Stoma complicationsa

13

31.7

 

11

13.9

 

 Device related replacements

28

  

45

  

 Patient related replacements

3

  

8

  

Total

31

75

 

53

67